Wu F - Search Results

1

Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.

Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira NT, Tan Y, Ci Y, Wu F, Dai X, Guo J, Huang YH, Fan C, Ren S, Sun Y, Freeman GJ, Sicinski P, Wei W. Zhang J, et al. Among authors: wu f. Nature. 2018 Jan 4;553(7686):91-95. doi: 10.1038/nature25015. Epub 2017 Nov 16. Nature. 2018. PMID: 29160310 Free PMC article.

2

Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt.

Zhang J, Xu K, Liu P, Geng Y, Wang B, Gan W, Guo J, Wu F, Chin YR, Berrios C, Lien EC, Toker A, DeCaprio JA, Sicinski P, Wei W. Zhang J, et al. Among authors: wu f. Mol Cell. 2016 Jun 16;62(6):929-942. doi: 10.1016/j.molcel.2016.04.023. Epub 2016 May 26. Mol Cell. 2016. PMID: 27237051 Free PMC article.

3

Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.

Wu F, Dai X, Gan W, Wan L, Li M, Mitsiades N, Wei W, Ding Q, Zhang J. Wu F, et al. Cancer Lett. 2017 Jan 28;385:207-214. doi: 10.1016/j.canlet.2016.10.021. Epub 2016 Oct 22. Cancer Lett. 2017. PMID: 27780719 Free PMC article.

4

Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6.

Tan Y, Ci Y, Dai X, Wu F, Guo J, Liu D, North BJ, Huo J, Zhang J. Tan Y, et al. Among authors: wu f. Oncotarget. 2017 Jul 18;8(29):47890-47901. doi: 10.18632/oncotarget.18141. Oncotarget. 2017. PMID: 28599312 Free PMC article.

5

SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.

Zhang J, Chen M, Zhu Y, Dai X, Dang F, Ren J, Ren S, Shulga YV, Beca F, Gan W, Wu F, Lin YM, Zhou X, DeCaprio JA, Beck AH, Lu KP, Huang J, Zhao C, Sun Y, Gao X, Pandolfi PP, Wei W. Zhang J, et al. Among authors: wu f. Dev Cell. 2019 Feb 11;48(3):329-344.e5. doi: 10.1016/j.devcel.2018.11.035. Epub 2018 Dec 27. Dev Cell. 2019. PMID: 30595538 Free PMC article.

6

Author Correction: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.

Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira NT, Tan Y, Ci Y, Wu F, Dai X, Guo J, Huang YH, Fan C, Ren S, Sun Y, Freeman GJ, Sicinski P, Wei W. Zhang J, et al. Among authors: wu f. Nature. 2019 Jul;571(7766):E10. doi: 10.1038/s41586-019-1351-8. Nature. 2019. PMID: 31270456

7

Aldosterone induces inflammatory cytokines in penile corpus cavernosum by activating the NF-κB pathway.

Wu F, Xiong ZQ, Mao SH, Hu JM, Wang JQ, Jiang HW, Ding Q. Wu F, et al. Asian J Androl. 2018 Jan-Feb;20(1):24-29. doi: 10.4103/aja.aja_8_17. Asian J Androl. 2018. PMID: 28382926 Free PMC article.

8

Gene expression analysis of peripheral blood cells reveals Toll-like receptor pathway deregulation in colorectal cancer.

Xu Y, Xu Q, Yang L, Liu F, Ye X, Wu F, Ni S, Tan C, Cai G, Meng X, Cai S, Du X. Xu Y, et al. Among authors: wu f. PLoS One. 2013 May 1;8(5):e62870. doi: 10.1371/journal.pone.0062870. Print 2013. PLoS One. 2013. PMID: 23650534 Free PMC article.

9

Overexpression of WDFY2 inhibits prostate cancer cell growth and migration via inactivation of Akt pathway.

Wang J, Chen X, Tong S, Zhou H, Sun J, Gou Y, Wu F, Hu J, Xu J, Ding G. Wang J, et al. Among authors: wu f. Tumour Biol. 2017 Jun;39(6):1010428317704821. doi: 10.1177/1010428317704821. Tumour Biol. 2017. PMID: 28653900 Free article.

10

Decrease in natural killer cell associated gene expression as a major characteristic of the immune status in the bloodstream of colorectal cancer patients.

Xu Y, Xu Q, Ni S, Liu F, Cai G, Wu F, Ye X, Meng X, Mougin B, Cai S, Du X. Xu Y, et al. Among authors: wu f. Cancer Biol Ther. 2011 Jan 15;11(2):188-95. doi: 10.4161/cbt.11.2.13670. Epub 2011 Jan 15. Cancer Biol Ther. 2011. PMID: 20962596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,997 results

Search Page